Tissue-resident Immune Cell Subsets in aGVHD
A Prospective Study on the Correlation Between Tissue-resident Immune Cell Subsets and Graft-versus-host Disease Following Hematopoietic Stem Cell Transplantation.
Nanfang Hospital, Southern Medical University
40 participants
Nov 16, 2024
OBSERVATIONAL
Conditions
Summary
This is a prospective study investigating the role of tissue-resident immune cell subsets in the occurrence and progression of graft-versus-host disease following hematopoietic stem cell transplantation. Approximately 40 subjects(including 20 grade 3-4 aGVHD patients and 20 grade 1-2 aGVHD patients ).
Eligibility
Inclusion Criteria3
- Voluntarily sign the informed consent form;
- Age 16-65 years old
- Clinically diagnosed with GVHD for the first time/receiving GVHD treatment.
Exclusion Criteria6
- Have a history of other tumors
- With poor compliance or mental disorders
- Infected with HIV and HCV
- With uncontrolled HBV infection
- With other autoimmune diseases
- Those who are judged by the researcher to be unsuitable to participate in this study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06708507